In this study, we investigated the oncogenic roles of a novel gene named MB21D2 which harbors a recurrent Q311E mutation which is overexpressed in head and neck squamous cell carcinoma (HNSCC). This evidence concerns the gene MB21D2 and head and neck squamous cell carcinoma.